Therefore, our results suggest that the decreased activity of the GC-KLF15-BCAA pathway in pre-symptomatic SMA mice is limited to skeletal muscle, whereas the increased activity in symptomatic SMA animals may be a more widespread phenomenon. The gene discussed is ARID4B; the disease is proximal spinal muscular atrophy.